lymphomas

Read news on lymphomas with our app.

Read more in the app

PARP1 Inhibitor Shows Promise Against EBV-Associated Lymphomas by Targeting EBNA2/MYC Pathway

Investigators develop novel treatment for T-cell leukemias and lymphomas